Gharagozloo, M., Mahmoud, S., Simard, C., Yamamoto, K., Bobbala, D., Ilangumaran, S., Smith, M. D., … Calabresi, P. A., Amrani, A., Gris, D. (2019). NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity. PLOS Biology17(9), e3000451.

Gonzalez Cardona, J., Smith, M. D., Wang, J., Kirby, L., Schott, J. T., Davidson, T., … Calabresi, P. A. (2019). Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis. PLOS ONE14(9), e0221747.

Kirby, L., Jin, J., Cardona, J. G., Smith, M. D., Martin, K. A., Wang, J., … Calabresi, P. A. (2019). Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nature Communications10(1), 3887.

Hollinger, K. R., Smith, M. D., Kirby, L. A., Prchalova, E., Alt, J., Rais, R., … Calabresi, P. A., Slusher, B. S. (2019). Glutamine antagonism attenuates physical and cognitive deficits in a model of MS. Neurology - Neuroimmunology Neuroinflammation6(6), e609.

Jin, J., Smith, M. D., Kersbergen, C. J., Kam, T.-I., Viswanathan, M., Martin, K., … Calabresi, P. A. (2019). Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis. Acta Neuropathologica Communications, 7(1), 125.

Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, … Calabresi, P.A. (2019) Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. doi:10.1093/brain/awz188

Bhargava, P., Mische, L., Smith, M. D., Harrington, E., Fitzgerald, K. C., Martin, K., … Calabresi, P. A. (2019). Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. BioRxiv, 627356.

Bhargava, P., Wicken, C., Smith, M. D., Strowd, R. E., Cortese, I., Reich, D. S., … Calabresi, P. A., Mowry, E. M. (2019). Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. Multiple Sclerosis and Related Disorders, 30, 136–140.

Horti, A. G., Naik, R., Foss, C. A., Minn, I., Misheneva, V., Du, Y., … Calabresi, P. A., … Pomper, M. G. (2019). PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proceedings of the National Academy of Sciences of the United States of America, 201812155.

Bhargava, P., Fitzgerald, K. C., Venkata, S. L. V., Smith, M. D., Kornberg, M. D., Mowry, E. M., … Calabresi, P. A. (2018). Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes. Annals of Clinical and Translational Neurology.

Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., Snyder, S. H. (2018). Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science.

Kornberg, M. D., Smith, M. D., Shirazi, H. A., Calabresi, P. A., Snyder, S. H., & Kim, P. M. (2018). Bryostatin-1 alleviates experimental multiple sclerosis. Proceedings of the National Academy of Sciences, 201719902.

Calabresi, P. A. (2018). Advances in multiple sclerosis: from reduced relapses to remedies. The Lancet Neurology, 17(1), 10–12.

Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018). Multiple Sclerosis. New England Journal of Medicine, 378(2), 169–180.

Smith, M. D., Calabresi, P. A., & Bhargava, P. (2017). Dimethyl fumarate treatment alters NK cell function in multiple sclerosis. European Journal of Immunology.

Baxi, E. G., DeBruin, J., Jin, J., Strasburger, H. J., Smith, M. D., Orthmann-Murphy, J. L., … Calabresi, P. A. (2017). Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia.

Smith, M. D., Martin, K. A., Calabresi, P. A., & Bhargava, P. (2017). Dimethyl fumarate alters B-cell memory and cytokine production in MS patients. Annals of Clinical and Translational Neurology, 4(5), 351–355.

Glenn, J. D., Smith, M. D., Xue, P., Chan-Li, Y., Collins, S., Calabresi, P. A., … Whartenby, K. A. (2017). CNS-targeted autoimmunity leads to increased influenza mortality in mice. The Journal of Experimental Medicine, 214(2), jem.20160517.

Orthmann-Murphy, J. L., & Calabresi, P. A. (2017). Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis. Clinical Pharmacology and Therapeutics, 101(1), 52–64.

Schott, J. T., Kirby, L. A., Calabresi, P. A., & Baxi, E. G. (2016). Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning. Journal of Visualized Experiments, (108), 53764.

Bhargava, P., & Calabresi, P. A. (2016). Metabolomics in multiple sclerosis. Multiple Sclerosis Journal, 22(4), 451–460.

Sotirchos, E. S., Bhargava, P., Eckstein, C., Van Haren, K., Baynes, M., Ntranos, A., … Calabresi, P. A. (2016). Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology, 86(4), 382–390.

Grishkan, I. V, Tosi, D. M., Bowman, M. D., Harary, M., Calabresi, P. A., & Gocke, A. R. (2015). Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties. Journal of Immunology (Baltimore, Md. : 1950).

Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., … Gocke, A. R. (2015). Transfer of Myelin-Reactive Th17 Cells Impairs Endogenous Remyelination in the Central Nervous System of Cuprizone-Fed Mice. Journal of Neuroscience, 35(22), 8626–8639.

Bhargava, P., Gocke, A., & Calabresi, P. A. (2015). 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. Journal of Neuroimmunology, 279, 20–4.

Baxi, E. G., Schott, J. T., Fairchild, A. N., Kirby, L. A., Karani, R., Uapinyoying, P., … Calabresi, P. A. (2014). A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation. Glia, 62(9), 1513–29.

Ntranos, A., Hall, O., Robinson, D. P., Grishkan, I. V, Schott, J. T., Tosi, D. M., … Gocke, A. R. (2014). FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. Journal of Neuroimmunology, 270(1–2), 13–21.

Grishkan, I. V, Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2013). 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences of the United States of America, 110(52), 21101–6.

Grishkan, I. V, Ntranos, A., Calabresi, P. A., & Gocke, A. R. Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cellular Immunology, 284(1–2), 68–74.

Hu, L., Wang, T., Gocke, A. R., Nath, A., Zhang, H., Margolick, J. B., … Calabresi, P. A. (2013). Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes. PloS One, 8(1), e54267.

Gocke, A. R., Lebson, L. A., Grishkan, I. V, Hu, L., Nguyen, H. M., Whartenby, K. A., … Calabresi, P. A. (2012). Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950), 188(12), 5877–86.

Hu, L., Gocke, A. R., Knapp, E., Rosenzweig, J. M., Grishkan, I. V, Baxi, E. G., … Calabresi, P. A. (2012). Functional blockade of the voltage-gated potassium channel Kv1.3 mediates reversion of T effector to central memory lymphocytes through SMAD3/p21cip1 signaling. The Journal of Biological Chemistry, 287(2), 1261–8.